SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer

SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer

Patients with high-grade serous ovarian cancer (HGSOC) have a very poor overall survival. Current therapeutic approaches do not bring benefit to all patients. Although genetic alterations and molecular mechanisms are well characterized, the molecular pathological conditions are poorly investigated....

Cijeli opis

Bibliografski detalji
Glavni autori: Stephanie Koller, Jonatan Kendler, Jasmine Karacs, Andrea Wolf, Caroline Kreuzinger, Isabel Von Der Decken, Felicitas Mungenast, Diana Mechtcheriakova, Wolfgang Schreiner, Andreas Gleiss, Walter Jäger, Dan Cacsire Castillo-Tong, Theresia Thalhammer
Format: Članak
Jezik:English
Izdano: Frontiers Media S.A. 2022-08-01
Serija:Frontiers in Pharmacology
Teme:
high-grade serous ovarian cancer
SLCO4A1
OATP4A1
NF-kB
ABCC3
SLCO4A1-AS1
Online pristup:https://www.frontiersin.org/articles/10.3389/fphar.2022.946348/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.946348/full

Slični predmeti